# A Study of Yiqi Yangyin Formula in the Treatment of Primary Sjogren's Syndrome

> **NCT07145060** · NA · NOT_YET_RECRUITING · sponsor: **China-Japan Friendship Hospital** · enrollment: 105 (estimated)

## Conditions studied

- Primary Sjögren's Syndrome (pSS)

## Interventions

- **DRUG:** Yiqi Yangyin Formula
- **DRUG:** Yiqi Yangyin Formula placebo

## Key facts

- **NCT ID:** NCT07145060
- **Lead sponsor:** China-Japan Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2028-01-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 105 (ESTIMATED)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07145060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07145060, "A Study of Yiqi Yangyin Formula in the Treatment of Primary Sjogren's Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07145060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*